Healy James

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Healy James
CIK #0001245624
EDGAR Form CIK 2011 - 2026
3 [0001245624]
4 [0001245624]
Form 3/4/5 Subject 2011 - 2026
BioAge Labs Inc
Healy James
Rapport Therapeutics Inc
Seaport Therapeutics Inc
Y-mAbs Therapeutics Inc
Natera Inc
Bolt Biotherapeutics Inc
Karuna Therapeutics Inc
ArriVent BioPharma Inc
Katabi Maha
CinCor Pharma Inc
Sofinnova Management X-A LLC
Sofinnova Management X LP
Sofinnova Venture Partners X LP
Vera Therapeutics Inc
Coherus Oncology Inc
Jade Biosciences Inc
Powell Michael
Sofinnova Management IX LLC
Sofinnova Venture Partners IX LP
Checkmate Pharmaceuticals Inc
Inozyme Pharma Inc
Akouos Inc
Iterum Therapeutics Ltd
NextCure Inc
Mehra Anand
Galera Therapeutics Inc
Entasis Therapeutics Holdings Inc
Sofinnova Management VIII LLC
Principia Biopharma Inc
Sofinnova Venture Partners VIII LP
PDS Biotechnology Corp
Azan Alain
Sofinnova Management VI LLC
Sofinnova Venture Partners VI L P
Buatois Eric
Sofinnova Venture Affiliates VI LP
Marinus Pharmaceuticals Inc
Sofinnova Venture Partners VI GmbH & Co KG
Amarin Corp PLC UK
Aclaris Therapeutics Inc
Akkaraju Srinivas
Synlogic Inc
aTYR Pharma Inc
Hyperion Therapeutics Inc
Spark Therapeutics Inc
Histogenics Corp
Intermune Inc
Alimera Sciences Inc
Aerie Pharmaceuticals Inc
Sofinnova Venture Partners VII L P
Sofinnova Management VII LLC
Aravive Inc
Tranzyme Inc
Anthera Pharmaceuticals Inc
Humanigen Inc
Sofinnova Management V 2005 LLC
Sofinnova Management V LLC
Sofinnova Venture Partners V LP
Sofinnova Venture Affiliates V LP
Sofinnova Venture Principals V LP
Kong Garheng
Durata Therapeutics Inc
Trius Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Y-mAbs Therapeutics Inc YMAB
Employee Stock Option (right to buy) · derivative
2025-06-30 Grant 33,450 $0.00
Y-mAbs Therapeutics Inc YMAB
Common Stock
2025-06-30 Grant 25,080 $0.00
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
2025-06-17 Grant 21,850 $0.00
BioAge Labs Inc BIOA
Stock Option (Right to Buy) · derivative
2025-06-05 Grant 22,000 $0.00
Natera Inc NTRA
Common Stock
2025-04-25 Grant 142
Natera Inc NTRA
Common Stock
2025-01-31 Grant 114
Natera Inc NTRA
Common Stock
2024-10-25 Grant 153
BioAge Labs Inc BIOA
Common Stock
2024-09-27 Conversion 1,638,236
BioAge Labs Inc BIOA
Common Stock
2024-09-27 Buy 18,353 $18.00 330,354
BioAge Labs Inc BIOA
Common Stock
2024-09-27 Buy 26,497 $18.00 476,946
BioAge Labs Inc BIOA
Common Stock
2024-09-27 Buy 588,888 $18.00 10,599,984
BioAge Labs Inc BIOA
Series D Preferred Stock · derivative
2024-09-27 Conversion 7,310,796
BioAge Labs Inc BIOA
Common Stock
2024-09-27 Buy 11,113 $18.00 200,034
BioAge Labs Inc BIOA
Common Stock
2024-09-27 Buy 21,814 $18.00 392,652
BioAge Labs Inc BIOA
Stock Option (Right to Buy) · derivative
2024-09-25 Grant 15,000 $0.00
Natera Inc NTRA
Common Stock
2024-07-26 Grant 177
Rapport Therapeutics Inc RAPP
Common Stock
2024-07-01 Buy 4,661 $25.02 116,618
Rapport Therapeutics Inc RAPP
Common Stock
2024-07-01 Buy 3,657 $24.21 88,536
Rapport Therapeutics Inc RAPP
Common Stock
2024-07-01 Buy 2,748 $26.06 71,613
Rapport Therapeutics Inc RAPP
Common Stock
2024-07-01 Buy 4,878 $25.02 122,048
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com